1. Show article details.

    Hologic Closes on Acquisition of Bolder Surgical

    Business Wire – 9:00 AM ET 11/30/2021

    Hologic, Inc. (HOLX), a global leader in women's health, has completed its previously announced acquisition of Bolder Surgical, a privately held, U.S.-based company that provides advanced energy vessel sealing surgical devices.

  2. Show article details.

    Hologic Pledges to Donate $5 Million to Improve Women’s Health, STEM Education and Social Justice

    Business Wire – 8:02 AM ET 11/30/2021

    Stepped-up philanthropic commitment, made on Giving Tuesday, will deepen the Company’s impact on local communities where its employees develop medical innovations Hologic, Inc. (HOLX), a global leader in medical technology with a primary focus on improving women’s health, announced on Giving Tuesday that it will expand its philanthropic efforts with $5 million in donations to nonprofit organizations l...

  3. Show article details.

    BRIEF-Hologic's Says Covid-19 Tests Detect Omicron Variant

    Reuters – 8:28 PM ET 11/29/2021

    Hologic Inc (HOLX): * HOLOGIC'S COVID-19 TESTS DETECT OMICRON VARIANT. * THREE SARS-COV-2 TESTS ALL DETECT RECENTLY EMERGED OMICRON VARIANT OF CORONAVIRUS THAT CAUSES COVID-19 Source text for Eikon: Further company coverage:

  4. Show article details.

    Hologic’s COVID-19 Tests Detect Omicron Variant

    Business Wire – 8:26 PM ET 11/29/2021

    Hologic, Inc. (HOLX) announced today that its three SARS-CoV-2 tests all detect the recently emerged Omicron variant of the coronavirus that causes COVID-19.

  5. Show article details.

    Hologic to Host Innovative Product Experiences and Medical Education Sessions On-site and Virtually at RSNA 2021

    Business Wire – 8:05 AM ET 11/23/2021

    Leader in women's health to showcase clinically proven solutions across the continuum of breast and skeletal health at annual meeting Hologic, Inc. (HOLX) will showcase its extensive portfolio of breast and skeletal health products, including screening and diagnostics solutions, breast biopsy, and breast cancer treatment and monitoring solutions, at the 107th Scientific Assembly and Annual Meeting of ...

  6. Show article details.

    Hologic to Webcast Presentation at Upcoming Virtual Investor Conference

    Business Wire – 4:04 PM ET 11/22/2021

    Hologic, Inc. (HOLX) announced today that the Company will present virtually at the 4th Annual Evercore ISI HealthCONx Conference on Tuesday, November 30 at 9:40 a.m. Eastern Time. The presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.

  7. Show article details.

    Hologic Announces European Launch of Genius™ Digital Diagnostics System for Cervical Cancer Screening

    Business Wire – 4:00 AM ET 11/04/2021

    --Powerful artificial intelligence combined with digital imaging designed to transform the screening process-- Hologic, Inc. (HOLX) announced today that its new Genius™ Digital Diagnostics System is now commercially available in Europe. This press release features multimedia.

  8. Show article details.

    Hologic to Launch the NovaSure® V5 Global Endometrial Ablation Device at Upcoming American Association of Gynecologic Laparoscopists 50th Global Congress

    Business Wire – 8:08 AM ET 11/02/2021

    With a 20-Year Legacy, the NovaSure System is the Most Trusted in Global Endometrial Ablation to Address Abnormal Uterine Bleeding Hologic, Inc. (HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation device at the American Association of Gynecologic Laparoscopists 50th Global Congress on. This press release features multimedia.

  9. Show article details.

    BRIEF-Hologic Announces Financial Results For Fourth Quarter Of Fiscal 2021

    Reuters – 5:37 PM ET 11/01/2021

    Hologic Inc (HOLX): * HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER OF FISCAL 2021. * Q4 REVENUE FELL 2.3 PERCENT TO $1.317 BILLION. * Q4 NON-GAAP EARNINGS PER SHARE $1.61. * Q4 GAAP EARNINGS PER SHARE $1.28. * Q4 EARNINGS PER SHARE VIEW $1.01, REVENUE VIEW $1.04 BILLION -- REFINITIV IBES DATA. * SEES FY REVENUE $3,750 MILLION - $4,000 MILLION.

  10. Show article details.

    Hologic Announces Financial Results for Fourth Quarter of Fiscal 2021

    Business Wire – 4:01 PM ET 11/01/2021

    – Revenue of $1.317 Billion Exceeds Expectations –. – Company Posts GAAP Diluted EPS of $1.28, Non-GAAP Diluted EPS of $1.61 –. – Financial Guidance for Fiscal 2022 Anticipates Solid Growth in Core Women’s Health Businesses and Continued Contributions to COVID-19 Fight –. MARLBOROUGH, Mass.

  11. Show article details.

    BRIEF-Hologic Says Multiplex Covid-19/Flu Test Commercially Available In North America And Europe

    Reuters – 6:33 PM ET 10/27/2021

    Hologic Inc (HOLX): * HOLOGIC'S MULTIPLEX COVID-19/FLU TEST NOW COMMERCIALLY AVAILABLE IN NORTH AMERICA AND EUROPE Source text for Eikon: Further company coverage:

  12. Show article details.

    Hologic’s Multiplex COVID-19/Flu Test Now Commercially Available in North America and Europe

    Business Wire – 4:02 PM ET 10/27/2021

    - Aptima® SARS-CoV-2/Flu Assay Tests Simultaneously for SARS-CoV-2, Influenza A and B on Fully Automated Panther® Molecular Diagnostics System - Hologic, Inc. (HOLX) announced today that its Aptima® SARS-CoV-2/Flu Assay is now available for the simultaneous detection and differentiation of three respiratory viruses that can present with overlapping clinical symptoms.

  13. Show article details.

    Hologic Debuts Documentary-Style Film Highlighting One Woman's Breast Cancer Journey Timed to Breast Reconstruction Awareness Day

    Business Wire – 8:15 AM ET 10/20/2021

    Global leader in women’s health partners with medical streaming platform, Mediflix, to provide first-of-its-kind awareness and education tool highlighting reconstructive options for breast cancer patients In conjunction with ongoing Breast Cancer Awareness Month efforts, Hologic, Inc. (HOLX), an innovative medical technology company primarily focused on improving women’s health, unveiled Carolina, a n...

  14. Show article details.

    Experts Issue a Call-to-Action to Recognize Periods as a Vital Sign of Health to Reduce Disparities in Uterine Fibroid Care for Black Women

    Business Wire – 8:00 AM ET 10/19/2021

    Black Women’s Health Imperative and Hologic (HOLX) hosted Unmuting Fibroids: Getting Loud for Equal Care - A Roundtable to Address Disparities in Uterine Fibroid Care A multidisciplinary group of experts agree that elevating awareness of a woman’s period as a vital sign of health would help to routinize and prioritize care for the uterine fibroids that impact eighty percent of Black women1.

  15. Show article details.

    BRIEF-Hologic To Acquire Bolder Surgical For $160 Million

    Reuters – 5:55 PM ET 10/14/2021

    Hologic Inc (HOLX): * HOLOGIC TO ACQUIRE BOLDER SURGICAL FOR $160 MILLION, EXPANDING ITS SURGICAL FRANCHISE. * Hologic Inc (HOLX) - EXPECTED TO GENERATE APPROXIMATELY $10 MILLION OF PRODUCT REVENUE THIS CALENDAR YEAR. * Hologic Inc (HOLX) - ACQUISITION IS EXPECTED TO BE SLIGHTLY DILUTIVE TO HOLOGIC'S NON-GAAP EARNINGS PER SHARE IN FISCAL 2022.

  16. Show article details.

    Hologic to Acquire Bolder Surgical for $160 Million, Expanding its Surgical Franchise

    Business Wire – 4:02 PM ET 10/14/2021

    -- Transaction Further Diversifies Hologic’s Product Offering and Broadens Access to Bolder Devices -- Hologic, Inc. (HOLX), a global leader in women's health, announced today that it has signed a definitive agreement to acquire Bolder Surgical, a privately held, U.S.-based company that provides advanced energy vessel sealing surgical devices, for approximately $160 million, subject to working capital...

  17. Show article details.

    Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2021 on Monday, November 1, 2021

    Business Wire – 4:05 PM ET 10/07/2021

    Hologic, Inc. (HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2021 on Monday, November 1, after the market closes. Interested participants may listen to the call by dialing 800-458-4121 or +1 323-794-2093 and referencing access code 2820462.

  18. Show article details.

    Hologic Launches Novodiag® System for On-Demand Molecular Testing in Europe

    Business Wire – 3:00 AM ET 10/05/2021

    Launch brings Novodiag’s benefits to broader range of European customers and expands Hologic’s offering of world-leading molecular scalable solutions Hologic, Inc. (HOLX) today announced its broad European launch of the Novodiag® system, a fully automated molecular diagnostic solution for on-demand testing of infectious diseases and antimicrobial resistance.

  19. Show article details.

    Hologic Rings Nasdaq Opening Bell for 15th Time to Kick Off Breast Cancer Awareness Month

    Business Wire – 6:00 AM ET 10/04/2021

    Leader in women’s health launches series of educational and awareness initiatives focused on eliminating racial disparities in breast cancer screening and care Hologic, Inc. (HOLX), an innovative medical technology company primarily focused on improving women’s health, announced today that CEO Steve MacMillan will ring the Nasdaq opening bell on October 4 to mark the beginning of Breast Cancer Awarene...

  20. Show article details.

    Hologic Expands its Omni® Hysteroscopy Offering in Europe

    Business Wire – 8:00 AM ET 09/30/2021

    New Omni 30° hysteroscope, Omni Lok cervical seal and Omni 5 French seal provide increased flexibility to support physicians both diagnosing and treating patients Hologic, Inc. (HOLX), a global leader in women's health, has launched its expanded Omni® suite, a comprehensive gynecological surgical offering designed to optimize diagnostic and operative hysteroscopy, in Europe, Africa and the Middle East.

Page:

Today's and Upcoming Events

  • Jan
    25

    HOLX to announce Q1 earnings (Unconfirmed)

Past Events (last 90 days)

  • Nov
    01

    HOLX announced Q4 earnings.

Data provided by Thomson Reuters © 2021

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.